-
FLAG Tag Peptide for Mechanistic Protein Workflows
2026-09-07
A translational framework for using the FLAG tag Peptide (DYKDDDDK) to validate recombinant VPS13C biology, connect cryo-EM findings to biochemical experiments, and improve protein purification decisions without confusing assay convenience with mechanistic evidence.
-
XAV-939: From Tankyrase Biology to Translation
2026-09-07
XAV-939, also known as NVP-XAV939, is more than a Wnt pathway inhibitor: it is a context-sensitive perturbation tool for connecting tankyrase biology with cancer, fibrosis, stem-cell differentiation, and barrier research. This thought-leadership article examines how to translate AXIN and β-catenin modulation into decision-ready experimental strategies while avoiding overinterpretation across disease models.
-
Protease Inhibitor Cocktail for Protein Workflows
2026-09-05
Protect lysates for Western blotting, co-immunoprecipitation, pull-downs, and signaling studies with broad protease coverage plus separately adjustable EDTA. This workflow-focused guide shows how to preserve TP53 and pathway proteins while avoiding EDTA-related problems in metal-dependent assays.
-
Potassium Channels and Renal Perfusion in Sepsis
2026-09-05
This study examined how ATP-sensitive and calcium-activated potassium channel blockade changes renal vascular responses to norepinephrine and phenylephrine in septic rats. Its main contribution was showing that channel inhibition may have little effect alone but can markedly worsen pressor-associated renal hypoperfusion, emphasizing the importance of drug–channel interactions in sepsis.
-
Rotigotine Transdermal Delivery in PD and RLS
2026-09-04
The reference paper explains how rotigotine’s lipid solubility and pharmacokinetic limitations led to development of a continuous transdermal system for Parkinson’s disease and restless legs syndrome. Its central implication is that sustained dopamine-receptor stimulation can provide clinically meaningful control of motor symptoms, off-time, and RLS symptoms while avoiding some limitations of short-acting oral delivery.
-
MDV3100 (Enzalutamide): Reliable Cell Assays
2026-09-04
This scenario-driven guide explains how MDV3100 (Enzalutamide), SKU A3003, can support interpretable cell-viability, proliferation, and resistance studies in androgen receptor-driven prostate cancer models. It covers mechanism, solvent compatibility, protocol optimization, resistance biology, and practical vendor-selection criteria.
-
Copper, Ferroptosis, and Neuronal Hypoxia
2026-09-03
This 2024 study identifies copper supplementation as a protective intervention in hypoxia-exposed HT22 neuronal cells, linking reduced intracellular copper with oxidative stress and ferroptosis. Its central mechanistic insight is a copper chaperone for SOD1/SOD1/GPX4 axis that connects copper homeostasis to neuronal antioxidant defense, while the cell-based design also defines important limits for translation to neonatal hypoxic-ischemic brain injury.
-
Lanabecestat: Precision BACE1 Workflows for AD Research
2026-09-02
Lanabecestat (AZD3293) enables controlled BACE1 enzyme inhibition across amyloid-beta, neuronal-function, and translational assay workflows. Its key use-case is dose-titrated amyloidogenic pathway modulation: researchers can identify partial amyloid-beta reduction while monitoring for exposure-associated synaptic effects.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-02
Cy5 NHS ester(Et) is a water-soluble amine-reactive fluorescent dye for covalent labeling of proteins, peptides, and other biomolecules. It is suitable for protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy, but not for ethanol-based dissolution or long-term storage of prepared solutions.
-
Cytoskeleton-Dependent Autophagy Under Compression
2026-09-01
The reference study shows that compressive mechanical stress induces autophagy through a cytoskeleton-dependent process, with microfilaments acting as the principal structural component and microtubules contributing secondarily. Its combination of force–time optimization, cytoskeletal perturbation, fluorescence imaging, and western blotting provides a useful framework for studying mechanotransduction in human cells.
-
Lysoptosis: A Conserved Cathepsin-Driven Death Pathway
2026-09-01
The reference study defines lysoptosis as a conserved lysosome-dependent cell death pathway in which lysosomal membrane permeabilization releases cathepsins that drive cytoplasmic proteolysis. By comparing Caenorhabditis elegans with mouse and human epithelial models, it shows that intracellular serpins can restrain this pathway, with cathepsin L emerging as the predominant executioner in the mammalian systems examined.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-31
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, frozen and paraffin tissue staining, flow cytometry, and ELISA workflows. It should be paired with validated goat IgG primaries and not used as a general secondary reagent for non-goat antibodies or unvalidated targets.
-
GOB-38 in Elizabethkingia anophelis
2026-08-31
The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, by combining recombinant expression, purified-enzyme biochemistry, genomic analysis, and bacterial co-culture. Its broad hydrolysis profile and distinctive active-site residues clarify how this enzyme may contribute to β-lactam resistance while showing why biochemical results should be interpreted alongside genomic and transmission evidence.
-
Bobcat339 for Reliable Epigenetic Assays
2026-08-30
Learn how Bobcat339 (SKU BA4643) can support controlled TET1/TET2 perturbation in cell viability, proliferation, and epigenetic experiments. This scenario-based guide connects biochemical potency data with practical controls, compound handling, and interpretation of DNA methylation outcomes.
-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-08-29
The reference study identifies PDHA1 lysine 83 succinylation as a metabolic-immune switch in cholangiocarcinoma. By increasing PDHA1 activity and promoting α-ketoglutarate accumulation, this modification activates macrophage OXGR1–MAPK signaling, suppresses MHC-II antigen presentation, and contributes to chemotherapy resistance.